Company news

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Announcement on Resolutions of the 18th Meeting of the 8th Board of Directors

November 12, 2025

Indicative Announcement on Internal Restructuring of the Ownership Structure at the Level Above the Controlling Shareholder and Persons Acting in Concert, and Resulting Reduction in the Number of Actual Controllers

November 11, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

October 31, 2025

Announcement on Resolutions of the 17th Meeting of the 8th Board of Directors

October 15, 2025

Announcement on Convening the 2025 Q3 Performance Briefing

October 8, 2025

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

September 1, 2025

Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration

August 29, 2025

Announcement on Progress in Idle Raised Funds Used for Cash Management

August 14, 2025

Announcement on the Subsidiary Passing On-site Inspection by FDA

August 12, 2025

2025 Semi-annual Report

August 5, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

August 3, 2025

Announcement on Completion of Industrial and Commercial Change Registration

July 9, 2025

Announcement on Obtaining Drug Registration Certificate by the Holding Subsidiary

July 1, 2025

Announcement on Implementation of Canceling Some Repurchased Shares

June 25, 2025

Announcement on Implementation of Dividend Distribution for 2024

June 11, 2025

Announcement on Adjusting the Total Cash Dividends for Profit Distribution in 2024

May 16, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 8, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

May 6, 2025

Announcement on Adding Provisional Proposal at 2024 Annual General Meeting

April 24, 2025

Report for Q1 2025

April 14, 2025

Announcement on Resolution of the 13th Meeting of the 8th Board of Directors

April 10, 2025

← Newer news releases